Key result
Frailty is linked to ~4.5-fold higher 30-day mortality in ACS patients aged ≥75 years.
Why the study?
Does frailty or infarct-related coronary artery occlusion predict 30-day mortality in patients aged ≥75 years with acute coronary syndrome?
Cohort (n=360)
Does frailty or infarct-related coronary artery occlusion predict 30-day mortality in patients aged ≥75 years with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Frailty is a powerful independent predictor of 30-day mortality in very old patients with AMI, outweighing chronological age and infarct-related coronary artery occlusion.
Background and Objectives: The prognostic value of frailty and infarct-related coronary artery occlusion (IRCAO) in very old patients with acute coronary syndrome (ACS) remains insufficiently studied. This study aimed to identify risk factors for 30-day mortality in patients aged ≥75 years with myocardial infarction, depending on the presence of IRCAO and frailty. Materials and Methods: A total of 360 patients (median age 80 [77; 84] years, 61.7% women) with ACS or acute myocardial infarction (AMI) were enrolled. Frailty was screened using the “Age is Not a Barrier” questionnaire in 228 patients. IRCAO was defined as TIMI 0–1 flow, absence of developed collateral circulation, and concordance between electrocardiogram changes and the affected coronary artery. The primary endpoint was all-cause mortality at 30 days. Kaplan–Meier survival analysis, Cox regression, and propensity score matching (PSM) were used. Results: Frailty was present in 21.9% (50/228) of screened patients and was associated with significantly lower 30-day survival (88.0% vs. 97.2%, log-rank p = 0.015). Frailty increased the risk of death by 4.5-fold (HR = 4.474; 95% CI: 1.365–14.663; p = 0.013). IRCAO was detected in 20.0% (72/360) and was a significant predictor in the overall cohort (HR = 1.792; 95% CI: 1.031–3.112; p = 0.038), but its significance disappeared in the frailty-screened subgroup. Age remained an independent predictor only in the overall cohort. The unadjusted association between percutaneous coronary intervention and higher mortality (HR = 2.37) was explained by confounding by indication; after PSM, no difference in mortality persisted (p = 1.000). Conclusions: Frailty is a powerful independent predictor of 30-day mortality in very old patients with AMI, outweighing chronological age and IRCAO. The prognostic value of IRCAO is mediated by frailty. The apparent harmful effect of percutaneous coronary intervention is explained by symptom severity rather than the procedure itself. Routine frailty assessment should be integrated into risk stratification for elderly ACS patients.
No takes yet. Share an insight, caveat, or question.
Арифовна et al. (2026) conducted a cohort in Acute Coronary Syndrome (n=360). Frailty vs. Non-frail was evaluated on all-cause mortality at 30 days (HR 4.474, 95% CI 1.365-14.663, p=0.013). Frailty increased the risk of 30-day all-cause mortality by 4.5-fold in patients aged ≥75 years with acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: